相关实验视频
Updated: Jan 13, 2026

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
36.4K
阿尔多斯降解酶参与EMT:新兴见解和当前提出的分子机制
Gemma Sardelli1, Francesca Felice1, Rossella Mosca1
1Biochemistry Unit, Department of Biology, University of Pisa, 56123 Pisa, Italy.
Biology
|October 29, 2025
概括
阿尔多减少酶 (AKR1B1) 促进上皮细胞-介质细胞过渡 (EMT),这是发育和疾病中的一个关键过程. 这篇评论探讨了AKR1B1的情况.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 阿尔多减少酶 (AKR1B1) 是阿尔多基因减少酶 (AKR) 家族的一部分,参与代谢和生理过程.
- 已知AKR1B1在聚途径和对活性碳类物种的防御中的作用,但其他功能尚不清楚.
- 新出现的证据将AKR1B1的表达和活动与上皮-介质酶过渡 (EMT) 联系起来.
研究的目的:
- 审查将AKR1B1与EMT关联的研究.
- 分析AKR1B1在驾驶EMT中提出的分子机制.
- 讨论AKR1B1抑制后对EMT的发现.
主要方法:
- 关于AKR1B1和EMT的研究的文献综述.
- 对拟议的分子机制的分析.
- 讨论AKR1B1抑制研究的实验结果.
主要成果:
- 在瘤和非瘤环境中,AKR1B1是EMT的强有力的促进者.
- AKR1B1驱动EMT的精确分子机制仍在调查中.
- 抑制AKR1B1已经显示出对EMT反应的影响.
结论:
- AKR1B1在促进EMT方面发挥着重要作用.
- 需要进一步的研究,以充分了解针对EMT相关疾病中的AKR1B1的分子机制和治疗潜力.
- 识别知识差距对于未来的研究方向至关重要.
相关概念视频
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Overview of Cell-Matrix Interactions
8.8K
The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...
8.8K
Phase I Reactions: Reductive Reactions
565
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
565
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K

